Lataa...
Efficacy and safety of ultra-long-acting insulin degludec
All patients with type 1 diabetes and significant numbers of those with type 2 diabetes are treated with insulin. Nonadherence to insulin regimen can impact glycaemic control. Insulin degludec is a new generation, ultra-long-acting basal insulin that forms soluble multihexamers at the injection site...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3474648/ https://ncbi.nlm.nih.gov/pubmed/23148194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018812437181 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|